1. Home
  2. LEE vs CTMX Comparison

LEE vs CTMX Comparison

Compare LEE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • CTMX
  • Stock Information
  • Founded
  • LEE 1890
  • CTMX 2008
  • Country
  • LEE United States
  • CTMX United States
  • Employees
  • LEE N/A
  • CTMX N/A
  • Industry
  • LEE Newspapers/Magazines
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • CTMX Health Care
  • Exchange
  • LEE Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • LEE 90.6M
  • CTMX 62.3M
  • IPO Year
  • LEE N/A
  • CTMX 2015
  • Fundamental
  • Price
  • LEE $11.46
  • CTMX $0.80
  • Analyst Decision
  • LEE
  • CTMX Buy
  • Analyst Count
  • LEE 0
  • CTMX 6
  • Target Price
  • LEE N/A
  • CTMX $5.77
  • AVG Volume (30 Days)
  • LEE 23.1K
  • CTMX 731.5K
  • Earning Date
  • LEE 02-06-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • LEE N/A
  • CTMX N/A
  • EPS Growth
  • LEE N/A
  • CTMX N/A
  • EPS
  • LEE N/A
  • CTMX 0.16
  • Revenue
  • LEE $600,264,000.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • LEE N/A
  • CTMX $22.55
  • Revenue Next Year
  • LEE N/A
  • CTMX N/A
  • P/E Ratio
  • LEE N/A
  • CTMX $4.93
  • Revenue Growth
  • LEE N/A
  • CTMX 33.66
  • 52 Week Low
  • LEE $7.57
  • CTMX $0.75
  • 52 Week High
  • LEE $19.63
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.32
  • CTMX 41.61
  • Support Level
  • LEE $11.40
  • CTMX $0.75
  • Resistance Level
  • LEE $13.69
  • CTMX $0.98
  • Average True Range (ATR)
  • LEE 0.80
  • CTMX 0.06
  • MACD
  • LEE -0.10
  • CTMX 0.00
  • Stochastic Oscillator
  • LEE 6.58
  • CTMX 20.13

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: